Home/Protocols/Brightening & Glow/572

prodermic 572

Kojic Protocol
SKU 572 · 30ml · Combo Peel
2,998
MRP 5,995
~24 sessions per jar
50% Expert Discount

Prodermic 572 is a kojic acid-forward tri-acid depigmentation protocol combining Kojic Acid 15% as the primary pigment-blocker with Glycolic Acid 30% for resurfacing and Lactic Acid 20% for hydrating exfoliation, totaling 65% active concentration.Designed as a clean hydroquinone alternative, the 572 attacks pigmentation from both ends: kojic acid blocks new pigment production while the dual-AHA blend removes existing pigmented dead skin from the surface.Indicated for PIH, uneven tone, and general brightening across Fitzpatrick II-V. ~24 sessions per 30ml jar.

Indications
PIH
PIH
Even Tone
Even Tone
Brightening
Brightening
Maintenance
Maintenance
Active Agents
Glycolic Acid
Lactic Acid
Kojic Acid
Volume
30ml
Sessions/Jar
~24
Peel Depth
Medium-Deep
Fitzpatrick
Professional use
Category
Peel
Shelf Life
24 months
Dispatch
Same Day
Min Order
1 unit
Same-Day Dispatch
Zero Minimum
GMP Certified
Prodermic Certified
Prodermic® Certified Seller
Only purchase Prodermic® products from certified partners and authorized distributors to ensure genuine formulations.
Formulation Technology

Kojic-Forward Depigmentation™

GKL-3KComplex

GKL-3K Complex — A kojic acid-forward tri-acid depigmentation system with glycolic resurfacing and lactic hydration.Kojic Acid 15% serves as the primary pigment-blocker, directly blocking melanin production as a clean hydroquinone alternative. Glycolic Acid 30% drives removal of existing pigmented dead skin and enhances active penetration. Lactic Acid 20% adds hydration and gentle surface exfoliation.A two-pronged approach at 65% total active concentration: block new pigment while clearing existing pigmentation.

Application Protocol

Recommended sequence for prodermic 572. Frequency: As prescribed by professional.

Step 01
Cleanse and prep skin thoroughly
Step 02
Apply product as directed by protocol
Step 03
Follow post-procedure care instructions
Mechanism of Action
Kojic (15%)
Powerful tyrosinase inhibition targeted at PIH.
AHA Blend
Glycolic + Lactic ensures penetration and hydration.
Kojic Acid 15%
Lead Active
65%
Total Concentration
Superficial
Peel Depth
Moderate
Aggression
Ideal Patient Profile

Patients specifically responding well to kojic acid, hydroquinone alternative seekers, mild-moderate pigmentation

Contraindications